Global Dengue Vaccines Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch's in-depth investigation and research, the global Dengue Vaccines market size will reach 643.42 Million USD in 2025 and is projected to reach 1,479.36 Million USD by 2032, with a CAGR of 12.63% (2025-2032). Notably, the China Dengue Vaccines market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Dengue vaccines are immunizations developed to protect against dengue fever, a viral disease transmitted through the bites of infected mosquitoes, primarily Aedes aegypti and Aedes albopictus. The vaccines are designed to stimulate the immune system to produce antibodies against the dengue virus, preventing or reducing the severity of the infection if a vaccinated person is exposed to the virus. Several dengue vaccines have been developed, including the CYD-TDV vaccine (Dengvaxia), which has been approved for use in some countries. Dengue vaccines are particularly important in regions where dengue is endemic and poses a significant public health threat. However, developing an effective dengue vaccine has been challenging due to the existence of multiple dengue virus serotypes, which require the vaccine to provide protection against all four serotypes. Continued research and efforts are focused on improving dengue vaccines to enhance their safety and efficacy, contributing to global efforts to control and prevent the spread of dengue fever.

The major global suppliers of Dengue Vaccines include Sanofi, Takeda, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Dengue Vaccines. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Dengue Vaccines market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Dengue Vaccines market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Dengue Vaccines industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Dengue Vaccines Include:

Sanofi

Takeda

Dengue Vaccines Product Segment Include:

Dengvaxia

TAK-003

Others

Dengue Vaccines Product Application Include:

Preventive Vaccination in Endemic Regions

Protection for Travelers

Integration into Routine Immunization Programs

Occupational Vaccination

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Dengue Vaccines Industry PESTEL Analysis

Chapter 3: Global Dengue Vaccines Industry Porter's Five Forces Analysis

Chapter 4: Global Dengue Vaccines Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Dengue Vaccines Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Dengue Vaccines Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Dengue Vaccines Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources